Alterity Therapeutics Limited (ATHE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alterity Therapeutics Lim...

    NASDAQ: ATHE · Real-Time Price · USD
    4.21
    0.02 (0.48%)
    At close: Oct 03, 2025, 3:59 PM
    4.24
    0.83%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Alterity Therapeutics Income Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 5.44M 4.02M 3.92M 5.12M 4.34M
    Cost of Revenue
    		 127.52K 214.3K 285.07K 364.67K 360.03K
    Gross Profit
    		 5.31M 3.8M 3.63M 4.76M 3.98M
    Operating Income
    		 -14.57M -19.6M -14.64M -15.5M -15.18M
    Interest Income
    		 n/a 268.42K 16.44K 2.5K 20.68K
    Pretax Income
    		 -12.08M -19.08M -13.7M -12.78M -15.31M
    Net Income
    		 -12.15M -19.12M -13.81M -12.85M -15.31M
    Selling & General & Admin
    		 5.48M 4.76M 5.04M 5.51M 6.87M
    Research & Development
    		 14.4M 18.64M 13.2M 14.75M 12.28M
    Other Expenses
    		 n/a n/a n/a n/a n/a
    Operating Expenses
    		 19.89M 23.41M 18.24M 20.26M 19.16M
    Interest Expense
    		 n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a -9.67K 51.48K 79.33K 21.81K
    Cost & Expenses
    		 20.01M 23.62M 18.52M 20.62M 19.52M
    Income Tax Expense
    		 68.06K 46.09K 104.46K 70.01K n/a
    Shares Outstanding (Basic)
    		 10.66M 6.08M 4.05M 4.01M 2.83M
    Shares Outstanding (Diluted)
    		 10.66M 6.08M 4.05M 4.01M 2.83M
    EPS (Basic)
    		 -1.14 -3.12 -3.42 -3.18 -5.4
    EPS (Diluted)
    		 -1.14 -3.12 -3.42 -3.18 -5.4
    EBITDA
    		 -14.63M -19.57M -14.6M -17.39M -15.16M
    EBIT
    		 -14.66M -19.61M -14.64M -17.45M -15.18M
    Depreciation & Amortization
    		 28.31K 35.34K 37.85K 54.21K 18.66K

    Add to Watchlist